Sexton Biotechnologies announced today that it has raised $5 million in growth capital and is the first company incubated by Indianapolis-based Cook Regentec to secure outside investment capital and spin out as an independent biotechnology company. In addition to ongoing research and product development, Sexton Biotechnologies will expand and scalecommercialization of its portfolio of container closure and media supplementation tools for cell and gene therapy bioproduction.

Biotechnology

Sexton Biotechnologies

Sexton Biotechnologies' headquarters in Indianapolis, IN, United States

Prashant Patel

Monica Wight, PMP

Mallory Wessel

Jay Gilliland

Hayley Steidinger

Jeff Enneking

The Sales and Support team at Sexton Biotechnologies is responsible for driving the commercialization of the company's innovative container closure and media supplementation tools. This team focuses on establishing and nurturing customer relationships, providing technical assistance, and ensuring exceptional service delivery to enhance client satisfaction in the cell and gene therapy sectors. With a blend of sales expertise and technical support, they play a crucial role in promoting product adoption and facilitating successful bioproduction processes.

Sales and Support

The Leadership Team at Sexton Biotechnologies is responsible for steering the company's strategic direction, overseeing operations, securing funding, and driving business development to scale the commercialization of their innovative bioproduction tools. This team ensures synergy between research, product development, and market expansion to achieve the company’s growth objectives.

Sexton Biotechnologies

Org chart

Teams

Sales and Support

Leadership Team

Offices

Sexton Biotechnologies

Org chart

Teams

Sales and Support

Leadership Team

Offices

Related companies